Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?Patent expiry trametinib?When genetic tenofovir alafenamide be available in us?Dabrafenib btd date 2023?Can lipitor's dosage change cause liver enzyme fluctuations?
See the DrugPatentWatch profile for Fomivirsen
Yes. Fomivirsen’s development code was ISIS-2922 (also written ISIS 2922). A bit of context: - Fomivirsen is an antisense oligonucleotide (phosphorothioate) designed to bind CMV mRNA and inhibit viral replication. - It was developed by Isis Pharmaceuticals (now Ionis Pharmaceuticals) and approved by the FDA in 1998 for CMV retinitis in AIDS patients, marketed as Vitravene. - The code ISIS-2922 reflects its early development designation within the Isis/ Ionis portfolio. If you want, I can share more details about its mechanism, target mRNA, or regulatory history.
Other Questions About Fomivirsen :